Structure

Physi-Chem Properties

Molecular Weight:  558.21
Volume:  542.959
LogP:  -0.029
LogD:  1.273
LogS:  -2.598
# Rotatable Bonds:  7
TPSA:  172.21
# H-Bond Aceptor:  11
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.188
Synthetic Accessibility Score:  5.108
Fsp3:  0.517
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.233
MDCK Permeability:  4.98567933391314e-05
Pgp-inhibitor:  0.005
Pgp-substrate:  0.077
Human Intestinal Absorption (HIA):  0.9
20% Bioavailability (F20%):  0.01
30% Bioavailability (F30%):  0.985

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.044
Plasma Protein Binding (PPB):  77.2568588256836%
Volume Distribution (VD):  0.352
Pgp-substrate:  18.569744110107422%

ADMET: Metabolism

CYP1A2-inhibitor:  0.034
CYP1A2-substrate:  0.023
CYP2C19-inhibitor:  0.022
CYP2C19-substrate:  0.111
CYP2C9-inhibitor:  0.086
CYP2C9-substrate:  0.098
CYP2D6-inhibitor:  0.009
CYP2D6-substrate:  0.057
CYP3A4-inhibitor:  0.334
CYP3A4-substrate:  0.239

ADMET: Excretion

Clearance (CL):  2.022
Half-life (T1/2):  0.871

ADMET: Toxicity

hERG Blockers:  0.163
Human Hepatotoxicity (H-HT):  0.949
Drug-inuced Liver Injury (DILI):  0.939
AMES Toxicity:  0.056
Rat Oral Acute Toxicity:  0.536
Maximum Recommended Daily Dose:  0.029
Skin Sensitization:  0.082
Carcinogencity:  0.044
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.036

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473147

Natural Product ID:  NPC473147
Common Name*:   LQIMVHNPYMFGPH-ROXCMIAGSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  LQIMVHNPYMFGPH-ROXCMIAGSA-N
Standard InCHI:  InChI=1S/C29H34O11/c1-12-8-19(37-21(32)9-15-4-6-16(31)7-5-15)23-14(3)28(36)40-27(23)22-13(2)18(10-17(12)22)38-29-26(35)25(34)24(33)20(11-30)39-29/h4-7,17,19-20,22-27,29-31,33-35H,1,3,8-11H2,2H3/t17-,19+,20+,22-,23+,24+,25-,26+,27+,29+/m0/s1
SMILES:  OC[C@H]1O[C@@H](OC2=C(C)[C@H]3[C@@H](C2)C(=C)C[C@H]([C@@H]2[C@@H]3OC(=O)C2=C)OC(=O)Cc2ccc(cc2)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3622757
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001543] Sesquiterpene lactones
            • [CHEMONTID:0001770] Guaianolides and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32813 ixeris dentata Species Asteraceae Eukaryota Roots n.a. n.a. PMID[26341134]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 18.2 uM PMID[463439]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 9.3 uM PMID[463439]
NPT27 Others Unspecified Activity = 105.7 % PMID[463439]
NPT27 Others Unspecified Activity = 102.7 % PMID[463439]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473147 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9571 High Similarity NPC194938
0.931 High Similarity NPC35097
0.9306 High Similarity NPC120728
0.9161 High Similarity NPC296659
0.9161 High Similarity NPC202391
0.898 High Similarity NPC96599
0.8944 High Similarity NPC31745
0.8944 High Similarity NPC220936
0.8919 High Similarity NPC240592
0.8919 High Similarity NPC117346
0.8828 High Similarity NPC186296
0.8776 High Similarity NPC143246
0.8776 High Similarity NPC474268
0.8776 High Similarity NPC119773
0.8776 High Similarity NPC475539
0.8767 High Similarity NPC77922
0.8767 High Similarity NPC473281
0.8767 High Similarity NPC251062
0.8767 High Similarity NPC184464
0.8733 High Similarity NPC289021
0.8733 High Similarity NPC158546
0.8707 High Similarity NPC210330
0.8707 High Similarity NPC475528
0.8699 High Similarity NPC293154
0.8699 High Similarity NPC475213
0.8699 High Similarity NPC152796
0.869 High Similarity NPC154262
0.869 High Similarity NPC137501
0.869 High Similarity NPC159387
0.869 High Similarity NPC7518
0.8662 High Similarity NPC169398
0.8639 High Similarity NPC63304
0.8627 High Similarity NPC475484
0.8618 High Similarity NPC257847
0.8609 High Similarity NPC474620
0.8609 High Similarity NPC475379
0.8591 High Similarity NPC473149
0.8582 High Similarity NPC281798
0.8582 High Similarity NPC254819
0.8571 High Similarity NPC475378
0.8553 High Similarity NPC478235
0.8523 High Similarity NPC212808
0.8483 Intermediate Similarity NPC101686
0.8483 Intermediate Similarity NPC65262
0.8483 Intermediate Similarity NPC469364
0.8477 Intermediate Similarity NPC161955
0.8477 Intermediate Similarity NPC478236
0.8477 Intermediate Similarity NPC478234
0.8446 Intermediate Similarity NPC478250
0.8431 Intermediate Similarity NPC203664
0.8429 Intermediate Similarity NPC173150
0.8429 Intermediate Similarity NPC471882
0.8429 Intermediate Similarity NPC35288
0.8429 Intermediate Similarity NPC45224
0.8429 Intermediate Similarity NPC471881
0.8429 Intermediate Similarity NPC156692
0.8421 Intermediate Similarity NPC69367
0.8414 Intermediate Similarity NPC471345
0.8411 Intermediate Similarity NPC189631
0.8408 Intermediate Similarity NPC130489
0.8408 Intermediate Similarity NPC208676
0.8378 Intermediate Similarity NPC296643
0.8377 Intermediate Similarity NPC299706
0.8377 Intermediate Similarity NPC115466
0.8377 Intermediate Similarity NPC61604
0.8377 Intermediate Similarity NPC245615
0.8377 Intermediate Similarity NPC229354
0.8357 Intermediate Similarity NPC61181
0.8344 Intermediate Similarity NPC179914
0.8333 Intermediate Similarity NPC114116
0.8322 Intermediate Similarity NPC478255
0.8312 Intermediate Similarity NPC194705
0.8302 Intermediate Similarity NPC145847
0.8301 Intermediate Similarity NPC229882
0.8301 Intermediate Similarity NPC158635
0.8299 Intermediate Similarity NPC220942
0.8299 Intermediate Similarity NPC49597
0.8298 Intermediate Similarity NPC103533
0.8278 Intermediate Similarity NPC320734
0.8278 Intermediate Similarity NPC473867
0.8269 Intermediate Similarity NPC38699
0.8264 Intermediate Similarity NPC471095
0.8264 Intermediate Similarity NPC471066
0.825 Intermediate Similarity NPC109990
0.8239 Intermediate Similarity NPC225307
0.8228 Intermediate Similarity NPC76211
0.8228 Intermediate Similarity NPC469384
0.8217 Intermediate Similarity NPC478055
0.8217 Intermediate Similarity NPC163635
0.8207 Intermediate Similarity NPC164172
0.8201 Intermediate Similarity NPC52097
0.82 Intermediate Similarity NPC242756
0.8194 Intermediate Similarity NPC235294
0.8194 Intermediate Similarity NPC46137
0.8188 Intermediate Similarity NPC46644
0.8182 Intermediate Similarity NPC267469
0.8182 Intermediate Similarity NPC87630
0.8182 Intermediate Similarity NPC179128
0.8182 Intermediate Similarity NPC116292
0.8182 Intermediate Similarity NPC469549
0.8176 Intermediate Similarity NPC324262
0.8176 Intermediate Similarity NPC62800
0.8169 Intermediate Similarity NPC288416
0.8169 Intermediate Similarity NPC106677
0.8165 Intermediate Similarity NPC187205
0.8165 Intermediate Similarity NPC49173
0.8165 Intermediate Similarity NPC4747
0.8165 Intermediate Similarity NPC475663
0.8165 Intermediate Similarity NPC226759
0.8165 Intermediate Similarity NPC104275
0.8165 Intermediate Similarity NPC286919
0.8163 Intermediate Similarity NPC472132
0.8163 Intermediate Similarity NPC470572
0.8158 Intermediate Similarity NPC208293
0.8151 Intermediate Similarity NPC471883
0.8129 Intermediate Similarity NPC11724
0.8125 Intermediate Similarity NPC469705
0.8125 Intermediate Similarity NPC17968
0.8125 Intermediate Similarity NPC117943
0.8125 Intermediate Similarity NPC470122
0.8125 Intermediate Similarity NPC477627
0.8125 Intermediate Similarity NPC293568
0.8117 Intermediate Similarity NPC478242
0.8116 Intermediate Similarity NPC469702
0.8116 Intermediate Similarity NPC282409
0.8108 Intermediate Similarity NPC469696
0.8101 Intermediate Similarity NPC228357
0.8099 Intermediate Similarity NPC471157
0.8095 Intermediate Similarity NPC123988
0.8089 Intermediate Similarity NPC478232
0.8086 Intermediate Similarity NPC180586
0.8082 Intermediate Similarity NPC136608
0.8082 Intermediate Similarity NPC254398
0.8082 Intermediate Similarity NPC38420
0.8079 Intermediate Similarity NPC263397
0.8079 Intermediate Similarity NPC302286
0.8079 Intermediate Similarity NPC116104
0.8079 Intermediate Similarity NPC237872
0.8079 Intermediate Similarity NPC89317
0.8079 Intermediate Similarity NPC88754
0.8079 Intermediate Similarity NPC204644
0.8075 Intermediate Similarity NPC476011
0.8069 Intermediate Similarity NPC138777
0.8069 Intermediate Similarity NPC246869
0.8069 Intermediate Similarity NPC219677
0.8069 Intermediate Similarity NPC225384
0.8065 Intermediate Similarity NPC104172
0.8065 Intermediate Similarity NPC12006
0.8065 Intermediate Similarity NPC88886
0.8065 Intermediate Similarity NPC35160
0.8065 Intermediate Similarity NPC162569
0.8063 Intermediate Similarity NPC138993
0.8063 Intermediate Similarity NPC474936
0.8058 Intermediate Similarity NPC476448
0.8058 Intermediate Similarity NPC476872
0.8058 Intermediate Similarity NPC469548
0.8058 Intermediate Similarity NPC476445
0.8054 Intermediate Similarity NPC171134
0.8054 Intermediate Similarity NPC321184
0.8054 Intermediate Similarity NPC321638
0.8054 Intermediate Similarity NPC328273
0.8052 Intermediate Similarity NPC473428
0.8052 Intermediate Similarity NPC23677
0.805 Intermediate Similarity NPC329997
0.8049 Intermediate Similarity NPC21956
0.8039 Intermediate Similarity NPC3982
0.8039 Intermediate Similarity NPC291153
0.8038 Intermediate Similarity NPC172920
0.8038 Intermediate Similarity NPC156624
0.8038 Intermediate Similarity NPC186316
0.8037 Intermediate Similarity NPC469396
0.8037 Intermediate Similarity NPC469458
0.8037 Intermediate Similarity NPC149002
0.8037 Intermediate Similarity NPC88176
0.8037 Intermediate Similarity NPC469419
0.8037 Intermediate Similarity NPC469459
0.8028 Intermediate Similarity NPC123704
0.8028 Intermediate Similarity NPC126991
0.8028 Intermediate Similarity NPC83218
0.8026 Intermediate Similarity NPC471028
0.8014 Intermediate Similarity NPC473924
0.8013 Intermediate Similarity NPC52664
0.8013 Intermediate Similarity NPC469623
0.8013 Intermediate Similarity NPC477700
0.8013 Intermediate Similarity NPC148080
0.7987 Intermediate Similarity NPC475195
0.7987 Intermediate Similarity NPC470330
0.7987 Intermediate Similarity NPC84789
0.7987 Intermediate Similarity NPC310252
0.7987 Intermediate Similarity NPC302583
0.7987 Intermediate Similarity NPC100558
0.7986 Intermediate Similarity NPC158673
0.7975 Intermediate Similarity NPC136757
0.7975 Intermediate Similarity NPC265600
0.7973 Intermediate Similarity NPC263829
0.7972 Intermediate Similarity NPC252114
0.7962 Intermediate Similarity NPC478268
0.7962 Intermediate Similarity NPC56184
0.7961 Intermediate Similarity NPC469367
0.7961 Intermediate Similarity NPC40305

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473147 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7933 Intermediate Similarity NPD7266 Discontinued
0.7824 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD7685 Pre-registration
0.7771 Intermediate Similarity NPD7228 Approved
0.7669 Intermediate Similarity NPD6234 Discontinued
0.7654 Intermediate Similarity NPD4965 Approved
0.7654 Intermediate Similarity NPD4967 Phase 2
0.7654 Intermediate Similarity NPD4966 Approved
0.764 Intermediate Similarity NPD8455 Phase 2
0.7578 Intermediate Similarity NPD37 Approved
0.7548 Intermediate Similarity NPD4628 Phase 3
0.7533 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD7199 Phase 2
0.74 Intermediate Similarity NPD3764 Approved
0.7389 Intermediate Similarity NPD6190 Approved
0.7384 Intermediate Similarity NPD6559 Discontinued
0.7384 Intermediate Similarity NPD7240 Approved
0.7368 Intermediate Similarity NPD6355 Discontinued
0.7365 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD6004 Phase 3
0.7355 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD6002 Phase 3
0.7355 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD6005 Phase 3
0.7353 Intermediate Similarity NPD3818 Discontinued
0.7299 Intermediate Similarity NPD8312 Approved
0.7299 Intermediate Similarity NPD8313 Approved
0.7278 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD9545 Approved
0.7215 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD6653 Approved
0.7186 Intermediate Similarity NPD7075 Discontinued
0.7168 Intermediate Similarity NPD7074 Phase 3
0.7161 Intermediate Similarity NPD7097 Phase 1
0.7143 Intermediate Similarity NPD1091 Approved
0.7143 Intermediate Similarity NPD230 Phase 1
0.7134 Intermediate Similarity NPD4380 Phase 2
0.7133 Intermediate Similarity NPD5647 Approved
0.7126 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD6663 Approved
0.7117 Intermediate Similarity NPD1653 Approved
0.7111 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD7054 Approved
0.7073 Intermediate Similarity NPD7458 Discontinued
0.7069 Intermediate Similarity NPD7472 Approved
0.7059 Intermediate Similarity NPD8127 Discontinued
0.7055 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD6233 Phase 2
0.7006 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD8166 Discontinued
0.6989 Remote Similarity NPD7251 Discontinued
0.6974 Remote Similarity NPD5736 Approved
0.6973 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6954 Remote Similarity NPD7799 Discontinued
0.6949 Remote Similarity NPD7808 Phase 3
0.6948 Remote Similarity NPD6798 Discontinued
0.6948 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6933 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6933 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6932 Remote Similarity NPD6797 Phase 2
0.6918 Remote Similarity NPD5762 Approved
0.6918 Remote Similarity NPD5763 Approved
0.6915 Remote Similarity NPD7680 Approved
0.6899 Remote Similarity NPD2799 Discontinued
0.6894 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6892 Remote Similarity NPD5125 Phase 3
0.6892 Remote Similarity NPD5126 Approved
0.6883 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6875 Remote Similarity NPD2424 Discontinued
0.6872 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6867 Remote Similarity NPD1608 Approved
0.6855 Remote Similarity NPD2438 Suspended
0.6855 Remote Similarity NPD2935 Discontinued
0.6853 Remote Similarity NPD969 Suspended
0.6845 Remote Similarity NPD6801 Discontinued
0.6842 Remote Similarity NPD6362 Approved
0.6836 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6832 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6831 Remote Similarity NPD7296 Approved
0.6829 Remote Similarity NPD2533 Approved
0.6829 Remote Similarity NPD2534 Approved
0.6829 Remote Similarity NPD2532 Approved
0.6828 Remote Similarity NPD2629 Approved
0.6826 Remote Similarity NPD7028 Phase 2
0.6821 Remote Similarity NPD7930 Approved
0.6813 Remote Similarity NPD8397 Clinical (unspecified phase)
0.681 Remote Similarity NPD5058 Phase 3
0.6805 Remote Similarity NPD7819 Suspended
0.68 Remote Similarity NPD3705 Approved
0.6796 Remote Similarity NPD8434 Phase 2
0.6795 Remote Similarity NPD4062 Phase 3
0.6792 Remote Similarity NPD7033 Discontinued
0.679 Remote Similarity NPD4109 Clinical (unspecified phase)
0.679 Remote Similarity NPD4110 Phase 3
0.679 Remote Similarity NPD3750 Approved
0.6788 Remote Similarity NPD6273 Approved
0.6786 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6781 Remote Similarity NPD7157 Approved
0.6774 Remote Similarity NPD3027 Phase 3
0.677 Remote Similarity NPD970 Clinical (unspecified phase)
0.677 Remote Similarity NPD5958 Discontinued
0.6768 Remote Similarity NPD6799 Approved
0.6765 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6765 Remote Similarity NPD5402 Approved
0.6754 Remote Similarity NPD7999 Approved
0.6753 Remote Similarity NPD2861 Phase 2
0.6752 Remote Similarity NPD4060 Phase 1
0.6747 Remote Similarity NPD5403 Approved
0.6746 Remote Similarity NPD1934 Approved
0.6737 Remote Similarity NPD7435 Discontinued
0.6732 Remote Similarity NPD2797 Approved
0.6728 Remote Similarity NPD6674 Discontinued
0.6726 Remote Similarity NPD6599 Discontinued
0.6725 Remote Similarity NPD7768 Phase 2
0.6725 Remote Similarity NPD3882 Suspended
0.6723 Remote Similarity NPD5844 Phase 1
0.6713 Remote Similarity NPD2067 Discontinued
0.6712 Remote Similarity NPD690 Clinical (unspecified phase)
0.6708 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6706 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6705 Remote Similarity NPD7473 Discontinued
0.6703 Remote Similarity NPD8150 Discontinued
0.6702 Remote Similarity NPD8319 Approved
0.6702 Remote Similarity NPD8320 Phase 1
0.669 Remote Similarity NPD7843 Approved
0.6686 Remote Similarity NPD7411 Suspended
0.6667 Remote Similarity NPD4534 Discontinued
0.6667 Remote Similarity NPD7095 Approved
0.6667 Remote Similarity NPD1549 Phase 2
0.6667 Remote Similarity NPD1876 Approved
0.6667 Remote Similarity NPD17 Approved
0.6667 Remote Similarity NPD1283 Approved
0.6667 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6648 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6648 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6648 Remote Similarity NPD6166 Phase 2
0.6646 Remote Similarity NPD2979 Phase 3
0.6645 Remote Similarity NPD1481 Phase 2
0.6643 Remote Similarity NPD6647 Phase 2
0.6629 Remote Similarity NPD6232 Discontinued
0.6629 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6627 Remote Similarity NPD5401 Approved
0.6626 Remote Similarity NPD1652 Phase 2
0.6624 Remote Similarity NPD3268 Approved
0.6623 Remote Similarity NPD3094 Phase 2
0.6622 Remote Similarity NPD9493 Approved
0.662 Remote Similarity NPD6685 Approved
0.6609 Remote Similarity NPD5494 Approved
0.6608 Remote Similarity NPD5761 Phase 2
0.6608 Remote Similarity NPD5760 Phase 2
0.6608 Remote Similarity NPD1465 Phase 2
0.6605 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6605 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6604 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6604 Remote Similarity NPD5124 Phase 1
0.6603 Remote Similarity NPD6832 Phase 2
0.6603 Remote Similarity NPD4908 Phase 1
0.66 Remote Similarity NPD1357 Approved
0.6597 Remote Similarity NPD6823 Phase 2
0.659 Remote Similarity NPD3749 Approved
0.6585 Remote Similarity NPD3400 Discontinued
0.6584 Remote Similarity NPD1510 Phase 2
0.6581 Remote Similarity NPD2798 Approved
0.6579 Remote Similarity NPD1535 Discovery
0.6579 Remote Similarity NPD6781 Approved
0.6579 Remote Similarity NPD6780 Approved
0.6579 Remote Similarity NPD6779 Approved
0.6579 Remote Similarity NPD6782 Approved
0.6579 Remote Similarity NPD6778 Approved
0.6579 Remote Similarity NPD6776 Approved
0.6579 Remote Similarity NPD6777 Approved
0.6578 Remote Similarity NPD6535 Approved
0.6578 Remote Similarity NPD6534 Approved
0.6573 Remote Similarity NPD1358 Approved
0.6573 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6573 Remote Similarity NPD3751 Discontinued
0.657 Remote Similarity NPD5353 Approved
0.657 Remote Similarity NPD3817 Phase 2
0.6568 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6568 Remote Similarity NPD3455 Phase 2
0.6564 Remote Similarity NPD8151 Discontinued
0.6561 Remote Similarity NPD7700 Phase 2
0.6561 Remote Similarity NPD7699 Phase 2
0.6556 Remote Similarity NPD3019 Approved
0.6556 Remote Similarity NPD2932 Approved
0.6554 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6543 Remote Similarity NPD1551 Phase 2
0.6543 Remote Similarity NPD4476 Approved
0.6543 Remote Similarity NPD4477 Approved
0.6541 Remote Similarity NPD4140 Approved
0.6541 Remote Similarity NPD1613 Approved
0.6541 Remote Similarity NPD1240 Approved
0.6541 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6538 Remote Similarity NPD9494 Approved
0.6536 Remote Similarity NPD9269 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data